PATH Launches New Vaccine Development Effort to Prevent Pneumonuia – Bill & Melinda Gates Foundation
Grant from the Bill & Melinda Gates Foundation to accelerate development of pneumococcal vaccines for developing countries
SEATTLE -- PATH today announced a new program aimed at preventing pneumonia, a major childhood illness that causes the deaths of up to one million children every year—primarily in developing countries. The program will seek a vaccine that is capable of addressing a broad range of strains of pneumococcus, a bacterium that causes pneumonia. PATH, an international nonprofit organization with over 27 years of global health experience, will work with public- and private-sector partners to identify and test promising pneumococcal vaccines. The five-year effort is supported by a US$75 million grant from the Bill & Melinda Gates Foundation.
To read the full press release, visit the PATH Web site.